Copyright: ©Author(s) 2026.
World J Clin Oncol. Apr 24, 2026; 17(4): 116329
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.116329
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.116329
Table 1 Patient characteristics, n (%)/mean ± SD/mean (range)
| Variable | |
| Total patients | 55 |
| Age (years) | 59.5 ± 13.1 |
| Sex | |
| Female | 35 (63.6) |
| Male | 20 (36.4) |
| Postoperative radiotherapy | 34 (61.8) |
| Mean total dose (Gy) | 62 (60-66) |
| Adjuvant chemotherapy | 5 (9.1) |
| Recurrence (local or distant) | 16 (29.1) |
| Most frequent metastasis site | Lung |
| Status at last follow-up (August 2025) | |
| Alive (with/without recurrence) | 31 (56.4) |
| Died of disease | 24 (43.6) |
| Follow-up duration (months) | Median = 89.4; mean = 94.7 ± 69.6 (0.9-306.6) |
- Citation: Stawarz K, Gorzelnik A, Klos W, Korzon J, Kissin F, Bienkowska-Pluta K, Stawarz G, Rusetska N, Zwoliński J. Prognostic value of clinicopathological parameters in adenoid cystic carcinoma: A retrospective cohort study. World J Clin Oncol 2026; 17(4): 116329
- URL: https://www.wjgnet.com/2218-4333/full/v17/i4/116329.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i4.116329